Dr. Gever supervises the IND Drug Discovery Group' High Throughput Screening (HTS team), which performs in-vitro screening of drugs and diverse chemical compounds in the pursuit of therapeutics that will be effective in treating Alzheimer's, Parkinson's and prion diseases. He is responsible for the design and execution of experiments, database management, data collection and analysis, quality control, and reporting results.